Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B)
Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B 5b (CYB5B) | Molecular Cancer | Full Text
What Have We Learnt from Genomics and Transcriptomics in Classic Hodgkin Lymphoma | Request PDF
PDF) Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children
Program - ISCAYAHL
Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B) | SpringerLink
Immunophenotypic features of all lymphomas | Download Table
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma | NEJM
New Strategies in Hodgkin Lymphoma: Better Risk Profiling and Novel Treatments | Clinical Cancer Research
CD30 expression in de novo diffuse large B‐cell lymphoma: a population‐based study from British Columbia - Slack - 2014 - British Journal of Haematology - Wiley Online Library
Gene expression profiling defines molecular subtypes of classical Hodgkin's disease | Oncogene
Fine-tuning of FOXO3A in cHL as a survival mechanism and a hallmark of abortive plasma cell differentiation. - Abstract - Europe PMC
High-resolution architecture and partner genes of <i>MYC</i> rearrangements in lymphoma with DLBCL morphology. - Abstract - Europe PMC
PDF) Pharmacological and genomic profiling identifies NF-??B-targeted treatment strategies for mantle cell lymphoma
IJMS | Free Full-Text | Engaging the Innate and Adaptive Antitumor Immune Response in Lymphoma | HTML
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma | NEJM
Franziska GEHRINGER | PostDoc Position | Dr. rer. nat. | Ulm University, Ulm | UULM | Institute of Physiological Chemistry
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma | NEJM
TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma. - Abstract - Europe PMC
High-resolution architecture and partner genes of <i>MYC</i> rearrangements in lymphoma with DLBCL morphology. - Abstract - Europe PMC
Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B) | SpringerLink
Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma | Nature Medicine
PROGRAM
CD30 expression in de novo diffuse large B‐cell lymphoma: a population‐based study from British Columbia - Slack - 2014 - British Journal of Haematology - Wiley Online Library
Frontiers | Microenvironment Cell Contribution to Lymphoma Immunity | Oncology
